U.S. House health panel reviews price transparency bills for patients and employers

Traders Union
All News
Financial News
House reviews health price transparency

Highlights

House Subcommittee on Health reviews transparency bills, including the Lower Costs, More Transparency Act of 2026, aiming to mandate clearer, real-time healthcare pricing data.
Proposed measures like the Patients Deserve Price Tags Act and CHECK Act would require commercial health plans to disclose prior authorization and claim denial rates, boosting competitive comparison.
If enacted, these bills would impose new disclosure requirements on insurers and providers, facilitating better-informed purchasing by employers and individuals and signaling continued congressional focus on cost controls.

Congressional review of transparency measures

As reported by the House Committee on Energy and Commerce, the Subcommittee on Health holds a hearing titled Lowering Health Care Costs for All Americans: Examining Policies to Increase Health Care Transparency under Chairman Morgan Griffith. Griffith says patients, families and employers have long dealt with a system in which the cost of care often remains unclear, sometimes until after services are delivered.

He says the committee is building on transparency initiatives established under President Trump and is focusing on policies intended to increase competition, expand consumer choice, reduce regulatory burdens and strengthen transparency across the healthcare system.

During the hearing, Congresswoman Mariannette Miller-Meeks highlights the Lower Costs, More Transparency Act of 2026, which the committee has previously passed. She says patients are encouraged to shop for care, but many still do not have access to clear, timely and usable cost information, while discussion drafts under review would require commercial health plans to provide greater transparency on prior authorization and claim denial rates.

Congressman John James says the Patients Deserve Price Tags Act is designed to make it easier for patients to compare prices for medical treatment and choose lower-cost options. He argues that unnecessary complexity in the system leaves patients paying substantially more for the same services and billing codes.

Potential effects on employers and healthcare markets

Congressman Nick Langworthy says the Clear Healthcare Expense Cost Knowledge, CHECK, Act is meant to bring hidden healthcare costs into the open and improve accountability throughout the system. He says patients should not face unexpected bills arriving weeks after treatment.

The package of proposals under discussion reflects a broader push to make healthcare pricing more visible for both consumers and employer-sponsored health plans, which often bear a significant share of medical spending. If enacted, the measures could increase disclosure requirements for insurers and providers while giving purchasers more tools to compare costs before care is delivered.

The hearing also signals continued congressional interest in using transparency policy as a cost-control mechanism in the U.S. healthcare sector. For employers, clearer pricing and claims data could support benefit design and purchasing decisions, while patients could gain more insight into out-of-pocket costs and administrative barriers tied to coverage.

Our earlier coverage of Ahold Delhaize U.S.’s $40 million settlement highlighted allegations that the company reported inflated “usual and customary” prescription drug prices on claims billed to Medicare Part D, Medicaid and TRICARE. We noted that the case underscored ongoing federal scrutiny of pharmacy pricing accuracy, including the role of whistleblowers and enforcement tools aimed at curbing practices that can drive up public healthcare spending.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.